Last updated: April 25, 2026
Who Supplies Desloratadine to the Pharma Industry?
What global suppliers provide desloratadine API and key intermediates?
Desloratadine is supplied as API and through upstream intermediates used in generic and brand manufacturing. The supplier landscape breaks into three practical buckets: API manufacturers, intermediate producers, and specialty trading houses that distribute API sourced from multiple plants.
API and desloratadine-related supply chain (industry-standard routes)
- API (desloratadine): Produced by companies with synthetic capability for antihistamine APIs and supplied to generic manufacturers, contract manufacturers, and formulators.
- Intermediates: Produced for downstream conversion into desloratadine via established medicinal chemistry routes used across the generic sector.
- Distribution: Large global chemical/pharma trading firms list multiple grades and packaging formats and can supply to multiple regions with regulatory documentation.
Which suppliers commonly appear for desloratadine API (by verified market presence)?
Below are supplier types that consistently show up in global procurement channels for desloratadine API. (Listings vary by grade, regulatory status, and packaging.)
1) Desloratadine API manufacturers
- Cipla
- Alembic Pharmaceuticals
- Hetero Drugs
- Torrent Pharmaceuticals
- Sun Pharmaceutical Industries
- Dr. Reddy’s Laboratories
- Mylan / Viatris (market presence via generics supply)
- Teva (market presence via generics supply)
2) Intermediates and upstream chemistry suppliers
- Companies producing antihistamine intermediates used for conversion to desloratadine, typically sold under intermediate catalog codes rather than drug substance naming.
3) Trading and distribution channels (API brokers / distributors)
- Firms that source desloratadine API from multiple plants and provide distribution documentation (CoA, CoC, regulatory dossiers where available).
What pharmaceutical suppliers list desloratadine API and sell into global tenders?
Procurement for desloratadine API is typically conducted through:
- Generic API tender platforms
- Regional pharma distributors
- Direct procurement from API plants
- Contract manufacturing organizations (CMOs) that qualify suppliers and hold regulatory files
In practice, buyers expect at least:
- GMP compliance for API supply
- CoA per batch
- Traceability and batch documentation for finished-dose manufacturing
Which regions dominate desloratadine API supply?
- India: Highest concentration of API supply participation for antihistamine molecules in the generic market.
- China: Large capacity for API and intermediates with broad export supply.
- Europe/US: More likely to appear via generics supply chains and distributor networks than as primary global API exporters for older antihistamine actives.
What grades and compliance terms matter in procurement?
Desloratadine API supply commonly uses:
- Ph. Eur. / USP-relevant specifications depending on customer region
- GMP-manufactured drug substance with batch CoA
- Packaging commonly provided in:
- Drums or fiber drums with liners
- Kegs
- Small pack formats for pilot and formulation work
What finished-dose manufacturers depend on desloratadine API sourcing?
Desloratadine is also widely formulated into tablets and syrups globally. Finished-dose brands and generics typically procure API from qualified suppliers and CMOs. This means API suppliers are indirectly tied to:
- Generic solid-dose manufacturers
- CMO formulation lines
- Regional brand licensees
How to map “supplier” to what buyers actually need
For business and R&D procurement, "supplier" usually means one of three operational roles:
- API manufacturing site (raw material source)
- Regulatory dossier holder (where DMF or equivalent file is maintained)
- Commercial supplier of record (what signs the PO and provides CoA)
Any tender that requires regulatory acceptance will prioritize role (2) or (3) even if the chemical synthesis site is elsewhere.
Key Takeaways
- Desloratadine is supplied globally as API and upstream intermediates, with procurement led by qualified API manufacturers and supplemented by distribution channels.
- India and China dominate active supply participation; Europe/US often show up more through generics supply and distributor networks.
- Buyers should align “supplier” definition to operational needs: manufacturing site, regulatory dossier holder, or supplier of record.
FAQs
1) Is desloratadine typically sourced as API or as a formulated finished product?
Primarily as API for generic manufacturers and CMOs producing tablets/syrups, with finished products sourced from formulators for distribution.
2) Which supplier category is most important for regulatory submissions?
The regulatory dossier holder (or the supplier that controls the regulatory file) is usually the critical procurement target.
3) What documents do purchasers typically require for desloratadine API?
Batch CoA, batch traceability, and GMP manufacturing documentation; many customers also require regulatory dossier references for review.
4) Do desloratadine suppliers provide both API and intermediates?
Some firms supply API directly; others focus on intermediates. Trading distributors often provide API from multiple plants.
5) Which regions supply most of the desloratadine API into global markets?
India and China are the main hubs for API and intermediate production and export.
References
[1] DrugBank. “Desloratadine.” https://go.drugbank.com/ (accessed 2026-04-25).
